Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Guido J Tricot"'
Autor:
Guido J Tricot, Vidya Kollu, Faiz Anwer, McBride Ali, Nusrat Jahan, Umar Zahid, Rafiullah Khan
Publikováno v:
American Journal of Therapeutics. 27:e194-e203
Background The International Myeloma Working Group has defined smoldering multiple myeloma (SMM) as the presence of 10%-60% plasma cells in the bone marrow and M-protein (IgG, IgA) ≥3 g/dL without end-organ damage (an increased calcium level, renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f833e7a868935cc55e4aa59f1165ec7e
https://doi.org/10.1097/mjt.0000000000001034
https://doi.org/10.1097/mjt.0000000000001034
Autor:
Guido J Tricot, Catherine M.T. Sherwin, Maurizio Zangari, Michael Boyer, Sabarinath Venniyil Radhakrishnan
Publikováno v:
Cell Transplantation
Cell Transplantation, Vol 28 (2019)
Cell Transplantation, Vol 28 (2019)
The efficacy of melphalan (MEL) 140 mg/m2 pre-transplant conditioning versus MEL 200 mg/m2 for the elderly is still debated. We hypothesized that single-agent intravenous busulfan (BU) would show significant anti-myeloma efficacy and be better tolera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a6c3d001bfe139828c4f5799f7ac27
http://europepmc.org/articles/PMC6923548
http://europepmc.org/articles/PMC6923548
Publikováno v:
Bone marrow transplantation. 53(11)
Tandem autologous transplants are generally the preferred therapy for newly diagnosed intermediate- and high-risk myeloma patients. More Jehovah's Witnesses (JW) are receiving single autologous peripheral blood stem cell transplants (PBSCTs). However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9a33d7aeffb6784661fed4eee306f2
https://pubmed.ncbi.nlm.nih.gov/29795417
https://pubmed.ncbi.nlm.nih.gov/29795417
Autor:
Reinaldo Franqui-Machin, Dawn E. Quelle, David Roodman, Michael H. Tomasson, Hongwei Xu, Mu Hao, John D. Shaughnessy, Ralph D. Sanderson, Lugui Qiu, Fenghuang Zhan, Siegfried Janz, Barthel Barlogie, Guido J Tricot, Ivana Frech
Publikováno v:
Leukemia
NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324f3dc5e3d1945cc7afe6d0f89130cb
https://pubmed.ncbi.nlm.nih.gov/28400617
https://pubmed.ncbi.nlm.nih.gov/28400617
Autor:
Guido J Tricot, Sarah L. Mott, Annick Tricot, Allyson Schultz, Kalyan Nadiminti, Sonya Behrends, Kamal Kant Singh Abbi, Fenghuang Zhan, Lindsay Dozeman
Publikováno v:
OncoTargets and therapy
Kalyan Nadiminti,1,2 Kamal Kant Singh Abbi,2,3 Sarah L Mott,2 Lindsay Dozeman,2 Annick Tricot,2 Allyson Schultz,2 Sonya Behrends,2,3 Fenghuang Zhan,2,3 Guido Tricot2,3 1Division of Hematology/Oncology, 2Holden Comprehensive Cancer Center, 3Department
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12bc2177d99799112008c7463e5e8363
https://pubmed.ncbi.nlm.nih.gov/28123303
https://pubmed.ncbi.nlm.nih.gov/28123303
Autor:
Lindsey Dozeman, Margarida Silverman, Matthew D. Krasowski, Umar Farooq, Guido J Tricot, Kalyan Nadiminti, Kamal Kant Singh Abbi, Annick Tricot
Publikováno v:
British journal of haematology. 174(4)
Response to treatment in patients with a plasma cell disorder is typically measured by evaluating the bone marrow and myeloma markers, including monoclonal protein spike and immunofixation (IFE) in blood and urine, and serum free light chains (sFLCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd7519c320cbd8447e6953149be32b7
https://pubmed.ncbi.nlm.nih.gov/27172326
https://pubmed.ncbi.nlm.nih.gov/27172326
Autor:
Ronald Walker, Bart Barlogie, Frits van Rhee, Jeffrey R. Sawyer, Sushil K. Gupta, Elias Anaissie, Ichiro Hanamura, Guido J Tricot, John D. Shaughnessy, Joshua Epstein, Klaus Hollmig, Fenghuang Zhan, Maurizio Zangari, Bart Burington, Mauricio Pineda-Roman, Yongsheng Huang, Simona Colla, Shmuel Yaccoby, John Crowley, James P. Stewart
Publikováno v:
Blood. 108:2020-2028
To better define the molecular basis of multiple myeloma (MM), we performed unsupervised hierarchic clustering of mRNA expression profiles in CD138-enriched plasma cells from 414 newly diagnosed patients who went on to receive high-dose therapy and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a6177aaf6113c2914c3b3078cca41b
https://doi.org/10.1182/blood-2005-11-013458
https://doi.org/10.1182/blood-2005-11-013458
Autor:
Pei Lin, Guido J Tricot, Susann Szmania, Ramesh B. Batchu, Fenghuang Zhan, Frits van Rhee, Sushil K. Gupta, Guilio C. Spagnoli, Amberly Moreno, John D. Shaughnessy, Mindy Pomtree
Publikováno v:
Blood. 105:3939-3944
The presence of a metaphase cytogenetic abnormality (CA) is the key negative predictor of outcome in patients with multiple myeloma (MM). Gene expression profiling (GEP) of such patients showed increased expression of NY-ESO-1 compared to patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f0de52183e96f4d6c6cf8ca496559c
https://doi.org/10.1182/blood-2004-09-3707
https://doi.org/10.1182/blood-2004-09-3707
Publikováno v:
Bone Marrow Transplantation. 33:955-962
Stem cell transplantation has assumed a prominent place in the treatment of multiple myeloma, but relative to patients with other malignancies there is surprisingly little information about the adjustment difficulties and quality-of-life changes that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49effa1075b82e93ca6c0dbb6ae8c2c8
https://doi.org/10.1038/sj.bmt.1704465
https://doi.org/10.1038/sj.bmt.1704465
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S177-S178
s / Biol Blood Marrow Transplant 22 (2016) S19eS481 S178 CMV serostatus was positive in 51 patients. Overall 23 (24.2% overall, 45.1% in seropositive patients) patients had CMV reactivation of which 11 had reactivation after first transplant, 8 after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132c03db6e154a9c0984787ea0916d40
https://doi.org/10.1016/j.bbmt.2015.11.548
https://doi.org/10.1016/j.bbmt.2015.11.548